Related Experiment Video

Updated: Jun 26, 2026

In Vitro Assay to Study Tumor-macrophage Interaction
08:36

In Vitro Assay to Study Tumor-macrophage Interaction

Published on: August 1, 2019

Tumor growth-promoting properties of macrophage migration inhibitory factor

Carlo Bifulco1, Katy McDaniel, Lin Leng

  • 1Department of Medicine, Pathology, Epidemiology and Public Health, Yale University School of Medicine, 300 Cedar Street, New Haven, CT 06520-8031, USA.

Current Pharmaceutical Design
|January 9, 2009
PubMed

Insights

Macrophage migration inhibitor factor (MIF) drives tumor growth and spread by affecting proliferation, apoptosis, and blood vessel formation. Its unique signaling pathways contribute to cancer progression and aggressiveness in human tumors.

Area of Science:

  • Immunology
  • Oncology
  • Molecular Biology

Background:

  • Macrophage migration inhibitor factor (MIF) is an ancient cytokine with diverse roles.
  • MIF is implicated in various aspects of tumor growth and progression.
  • Its unique signaling properties distinguish it from typical immune cytokines.

Purpose of the Study:

  • To explore the multifaceted roles of MIF in tumorigenesis.
  • To elucidate the signaling pathways regulated by MIF in cancer.
  • To investigate the association between MIF and tumor aggressiveness.

Main Methods:

  • Review of in vitro and in vivo cancer models.
  • Analysis of signaling pathways including ERK-1/2, AKT, JAB1, p53, SCF ubiquitin ligases, and HIF-1.
  • Correlation studies between MIF production and tumor characteristics.

Main Results:

  • MIF promotes tumor proliferation, angiogenesis, and invasion.
  • MIF influences apoptosis and cell cycle control.
  • Elevated MIF levels correlate with increased tumor aggressiveness and metastatic potential.

Conclusions:

  • MIF possesses significant pro-tumorigenic properties.
  • MIF's unique signaling pathways are central to its role in cancer.
  • Targeting MIF may offer therapeutic strategies for cancer treatment.

More Related Videos

Studying the Effects of Tumor-Secreted Paracrine Ligands on Macrophage Activation using Co-Culture with Permeable Membrane Supports07:44

Studying the Effects of Tumor-Secreted Paracrine Ligands on Macrophage Activation using Co-Culture with Permeable Membrane Supports

Published on: November 28, 2019

A Macrophage-Tumor Spheroid Co-Invasion Assay09:01

A Macrophage-Tumor Spheroid Co-Invasion Assay

Published on: January 24, 2025

Related Concept Videos

The Tumor Microenvironment02:17

The Tumor Microenvironment

Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...